DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
SACCHAROMYCES BOULARDII
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SACCHAROMYCES BOULARDII
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL VALERATE; ESTRADIOL VALERATE; DIENOGEST
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ESTRADIOL VALERATE; ESTRADIOL VALERATE; DIENOGEST
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IPRAGLIFLOZIN
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
IPRAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
None
UNII:
3N2N8OOR7X
Molecule Type:
Small molecule
Molecular Formula:
C21H21FO5S
Molecular Weight:
404.46
AlogP:
2.15
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
4.0
Source:
ALUMINUM CHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Hyperhidrosis; Acne Vulgaris
Unknown
ALUMINUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
3CYT62D3GA
Molecule Type:
Small molecule
Molecular Formula:
AlCl3
Molecular Weight:
133.34
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SODIUM IODIDE I-131
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
SODIUM IODIDE I-131
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTULIFT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BOTULIFT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SUBSTANCE P
4
Protein
Approved
Unknown
Unknown
Diabetes Mellitus, Type 1; Rhinitis, Allergic, Seasonal
Unknown
SUBSTANCE P
×
Maximum Phase:
4
First Approval:
None
UNII:
675VGV5J1D
Molecule Type:
Protein
Molecular Formula:
C63H98N18O13S
Molecular Weight:
1347.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ICHTHAMMOL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ICHTHAMMOL
×
Maximum Phase:
4
First Approval:
None
UNII:
NQ14646378
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FORMOTEROL FUMARATE; GLYCOPYRROLATE
4
Combination
Approved
Unknown
INHALATION
Unknown
Unknown
FORMOTEROL FUMARATE; GLYCOPYRROLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALVERINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Hepatocyte nuclear factor 4-alpha activator
ALVERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
46TIR1560O
Molecule Type:
Small molecule
Molecular Formula:
C20H27N
Molecular Weight:
281.44
AlogP:
4.57
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
9.0
Source:
CHLOROPHENOTHANE
4
Small molecule
Approved
Unknown
Unknown
Ectoparasitic Infestations
Unknown
CHLOROPHENOTHANE
×
Maximum Phase:
4
First Approval:
None
UNII:
CIW5S16655
Molecule Type:
Small molecule
Molecular Formula:
C14H9Cl5
Molecular Weight:
354.49
AlogP:
6.5
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ADALIMUMAB-FKJP
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ADALIMUMAB-FKJP
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STRONTIUM CHLORIDE SR-89
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
STRONTIUM CHLORIDE SR-89
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; VALSARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; VALSARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIMEBUTINE MALEATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TRIMEBUTINE MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUFEXAMAC
4
Small molecule
Approved
Unknown
Unknown
Arthralgia; Myalgia; Rheumatic Diseases
Unknown
BUFEXAMAC
×
Maximum Phase:
4
First Approval:
None
UNII:
4T3C38J78L
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO3
Molecular Weight:
223.27
AlogP:
1.91
PSA:
58.56
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CAMPHOR
4
Small molecule
Approved
Unknown
Unknown
Arthritis; Back Pain; Cardiovascular Diseases; Common Cold; Contusions; Cough; Herpes Labialis; Inflammation; Insect Bites and Stings; Nasal Obstruction; Pain; Pruritus; Rectal Diseases; Rhinitis, Allergic, Seasonal; Sprains and Strains
Unknown
CAMPHOR
×
Maximum Phase:
4
First Approval:
None
UNII:
5TJD82A1ET
Molecule Type:
Small molecule
Molecular Formula:
C10H16O
Molecular Weight:
152.24
AlogP:
2.4
PSA:
17.07
HBD:
0.0
HBA:
#RotB:
0.0
Source:
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INFLIXIMAB-AXXQ
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INFLIXIMAB-AXXQ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INTERFERON BETA
4
Protein
Approved
Unknown
Unknown
Carcinoma, Merkel Cell; Melanoma; Macular Edema; Multiple Sclerosis; Uveitis, Intermediate
Unknown
INTERFERON BETA
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZODIAZEPINE
4
Small molecule
Approved
Unknown
Unknown
Anxiety
Unknown
BENZODIAZEPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
M0Q7802G2B
Molecule Type:
Small molecule
Molecular Formula:
C9H8N2
Molecular Weight:
144.18
AlogP:
2.11
PSA:
24.39
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CARBON DIOIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CARBON DIOIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUCILLAMINE
4
Small molecule
Approved
Unknown
Unknown
Cystinuria; Gout; Arthritis, Rheumatoid; Rheumatic Diseases; Severe Acute Respiratory Syndrome
Unknown
BUCILLAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
R80LRA5WTF
Molecule Type:
Small molecule
Molecular Formula:
C7H13NO3S2
Molecular Weight:
223.32
AlogP:
0.19
PSA:
66.4
HBD:
4.0
HBA:
#RotB:
4.0
Source:
VONOPRAZAN
4
Small molecule
Approved
Unknown
Unknown
Gastroesophageal Reflux; Helicobacter Infections; Peptic Ulcer
Unknown
VONOPRAZAN
×
Maximum Phase:
4
First Approval:
None
UNII:
1R5L3J156G
Molecule Type:
Small molecule
Molecular Formula:
C17H16FN3O2S
Molecular Weight:
345.4
AlogP:
2.65
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIMETAZIDINE
4
Small molecule
Approved
Unknown
Unknown
Acute-On-Chronic Liver Failure; Heart Failure; Cardiomyopathy, Hypertrophic; Cardiotoxicity; Hypertension, Pulmonary; Cardiovascular Diseases
Unknown
TRIMETAZIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
N9A0A0R9S8
Molecule Type:
Small molecule
Molecular Formula:
C14H22N2O3
Molecular Weight:
266.34
AlogP:
1.12
PSA:
42.96
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOGUANIL PAMOATE
4
Small molecule
Approved
Unknown
Unknown
Malaria
Dihydrofolate reductase inhibitor
CYCLOGUANIL PAMOATE
×
Maximum Phase:
4
First Approval:
None
UNII:
TCO0SY4N3D
Molecule Type:
Small molecule
Molecular Formula:
C45H44Cl2N10O6
Molecular Weight:
891.82
AlogP:
1.53
PSA:
80.0
HBD:
2.0
HBA:
#RotB:
1.0
Source:
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DESLORATADINE; PSEUDOEPHEDRINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DESLORATADINE; PSEUDOEPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POTASSIUM CHLORIDE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
POTASSIUM CHLORIDE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HALQUINOLS
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
HALQUINOLS
×
Maximum Phase:
4
First Approval:
None
UNII:
Z7Z4BX535U
Molecule Type:
Small molecule
Molecular Formula:
C27H17Cl4N3O3
Molecular Weight:
573.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
incobotulinumtoxinA
4
Unknown
Approved
OTHER
INJECTION
Unknown
Synaptosomal-associated protein 25 inhibitor
incobotulinumtoxinA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BELVIQ
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BELVIQ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
298
299
300
301
302
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA